Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D051379:Mice; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors*; D009374:Neoplasms, Experimental / Q000378:metabolism / Q000532:radiotherapy*; D011836:Radiation Tolerance; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D015398:Signal Transduction
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D009363:Neoplasm Proteins; D011993:Recombinant Fusion Proteins; D066246:ErbB Receptors; D000068818:Cetuximab